Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 44
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Sud Med Ekspert ; 64(6): 50-55, 2021.
Artigo em Russo | MEDLINE | ID: mdl-34814646

RESUMO

The objective of the study is to analyze the publications on biochemical aspects of myorenal syndrome (crush-syndrome) pathogenesis. Factors of trauma and other etiologies significant in terms of forensic practice that cause muscle tissue destruction are presented. Molecular processes in rhabdomyolysis and subsequent renal damage, the establishment of the sequence of which is important for forensic medicine, are outlined. The study results will improve our understanding of the of myorenal syndrome pathophysiology, its biochemical features, and optimize methods for its forensic diagnosis.


Assuntos
Injúria Renal Aguda , Síndrome de Esmagamento , Rabdomiólise , Medicina Legal , Humanos , Rim , Rabdomiólise/etiologia
2.
Vavilovskii Zhurnal Genet Selektsii ; 25(6): 620-630, 2021 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-34782881

RESUMO

Narrow-leaved lupine (Lupinus angustifolius L.) is a cultivated multipurpose species with a very short history of domestication. It is used as a green manure, and for feed and food. This crop shows good prospects for use in pharmacology and as a source of f ish feeds in aquaculture. However, its genetic potential for the development of productive and adaptable cultivars is far from being realized. For crop species, the genetic base of the cultivated gene pool has repeatedly been shown as being much narrower than that of the wild gene pool. Therefore, eff icient utilization of a species' genetic resources is important for the crop's further improvement. Analyzing the information on the germplasm collections preserved in national gene banks can help perceive the worldwide diversity of L. angustifolius genetic resources and understand how they are studied and used. In this context, the data on the narrow-leaved lupine collection held by VIR are presented: its size and composition, the breeding status of accessions, methods of studying and disclosing intraspecif ic differentiation, the classif ications used, and the comparison of this information with available data on other collections. It appeared that VIR's collection of narrow-leaved lupine, ranking as the world's second largest, differed signif icantly from others by the prevalence of advanced cultivars and breeding material in it, while wild accessions prevailed in most collections. The importance of the wild gene pool for the narrow-leaved lupine breeding in Australia, the world leader in lupine production, is highlighted. The need to get an insight into the species' ecogeographic diversity in order to develop cultivars adaptable to certain cultivation conditions is shown. The data on the testing of VIR's collection for main crop characters valuable for breeders are presented. Special attention is paid to the study of accessions with limited branching as a promising gene pool for cultivation in relatively northern regions of Russia. They demonstrate lower but more stable productivity, and suitability for cultivation in planting patterns, which has a number of agronomic advantages. Analyzing the work with narrow-leaved lupine genetic resources in different national gene banks over the world helps shape the prospects of further activities with VIR's collection as the only source of promising material for domestic breeding.

3.
Vestn Khir Im I I Grek ; 175(5): 36-40, 2016.
Artigo em Inglês, Russo | MEDLINE | ID: mdl-30422445

RESUMO

The chemoinfusions (310) were carried out in celiac trunk in 167 patients with non-removed pancreas cancer at the period from 2000 to 2015. Locally advanced timorous process (stage III, n=79) was revealed in 79 patients and liver metastases (stage IV, n=88) were noted in 88 cases. The celiac axis infusion by Gemcitabine (1000 mg/m²) was applied for patients and GEMOX (Gemcitabine+Oxaliplatin 75 mg/m²) has been using since 2012. Symptomatic improvement such as decrease of pain, growth of body weight was noted in majority of patients. An average lifetime, median and one-year survival consisted of 7,6 months, 5,8 months and 10%. The patients (133) were treated by 1­2 cycles and after that by course of total body chemotherapeutics. There weren't any serious complications. Toxic manifestations of chemotherapy weren't higher than I­II degree and they were arrested by corrective therapy in 92 patients (55%). The celiac axis infusion is safe in patients with locally advanced and inoperable pancreas cancer. Symptomatic improvement showed the most patients. The objective response to the treatment had 20% patients and performance of repeated cycles led to increase of their survival.


Assuntos
Adenocarcinoma , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Desoxicitidina/análogos & derivados , Neoplasias Hepáticas , Pâncreas , Neoplasias Pancreáticas , Adenocarcinoma/tratamento farmacológico , Adenocarcinoma/patologia , Angiografia/métodos , Antimetabólitos Antineoplásicos/administração & dosagem , Desoxicitidina/administração & dosagem , Feminino , Humanos , Infusões Intra-Arteriais/métodos , Neoplasias Hepáticas/tratamento farmacológico , Neoplasias Hepáticas/secundário , Masculino , Pessoa de Meia-Idade , Estadiamento de Neoplasias , Compostos Organoplatínicos/administração & dosagem , Pâncreas/irrigação sanguínea , Pâncreas/diagnóstico por imagem , Neoplasias Pancreáticas/tratamento farmacológico , Neoplasias Pancreáticas/patologia , Sistema Porta/diagnóstico por imagem , Resultado do Tratamento
4.
Vestn Ross Akad Med Nauk ; (7-8): 54-66, 68, 2014.
Artigo em Russo | MEDLINE | ID: mdl-25563005

RESUMO

In 2010, the Russian Federation (RF) registered palivizumab--innovative drug, based on monoclonal antibodies for passive immunization of seasonal respiratory syncytial virus (RSV) infection in children of disease severe progress risk group, which include primarily premature infants, children with bronchopulmonary dysplasia and hemodynamically significant congenital heart disease. Currently, palivizumab is included in the list of recommended medicines and medical care standards of different countries, including Russia. In the review the results of Russian research on the progress of RSV infection, its epidemiology and immunization experience gained over the 2010-2014 period are summarized in relation to the foreign data. During the four epidemic seasons palivizumab immunization covered more than 3,200 children of severe RSV infection risk group with a progressive annual increase in the number of patients who received the drug. Geography of palivizumab immunization is also greatly expanded in our country during this time. If during the first two seasons measures of immunization were taken mainly in Moscow and St. Petersburg, at the present time, thirty one territorial entities of the Russian Federation have the experience in the drug application. Analysis of the results of RSV infection immunization (made in several regions) confirms the high clinical efficacy and palivizumab safety already demonstrated in international studies. In addition, the analysis presents the potential to improve the efficiency of the integrated RSV infection immunization programs, realizing in the establishment of high-risk child group register, adequate counseling for parents, as well as the development of the routing of patients and coordination of interaction between different health institutions during the immunization.


Assuntos
Anticorpos Monoclonais Humanizados/administração & dosagem , Infecções por Vírus Respiratório Sincicial , Antivirais/administração & dosagem , Displasia Broncopulmonar/epidemiologia , Feminino , Cardiopatias Congênitas/epidemiologia , Humanos , Programas de Imunização/métodos , Programas de Imunização/organização & administração , Lactente , Recém-Nascido , Recém-Nascido Prematuro , Recém-Nascido de muito Baixo Peso , Masculino , Palivizumab , Avaliação de Programas e Projetos de Saúde/estatística & dados numéricos , Sistema de Registros , Infecções por Vírus Respiratório Sincicial/epidemiologia , Infecções por Vírus Respiratório Sincicial/prevenção & controle , Fatores de Risco , Federação Russa/epidemiologia
5.
Artigo em Russo | MEDLINE | ID: mdl-16438374

RESUMO

The comparative study of the biological properties of S. enteritidis and S. typhimuruim, isolated from patients and convalescent carriers, was carried out. Factors inactivating the components of the local immunity of the intestine (lysozyme, complement, lactoferrin, IgG, IgM and IgA) were detected in the causative agents of Salmonella infections. The spread and expression degree of properties of a causative agent were serovar-depended: high penetration characteristics and the expression of anti-lactoferrin and anti-immunoglobulin activity were characteristic of S. typhimurium. S. enteritidis strains isolated from patients with carrier state formed in the convalescence period were found to have higher persistence level. In co-profiltrates obtained from carriers at the peak of the disease and during convalescence lower levels of IgM, IgG, sIgA, complement and lactoferrin were determined in comparison with those in coprofiltrates obtained from patients in whom no subsequent carrier state was formed. These results indicate that an increase in the persistence of salmonellae, occurring simultaneously with the local immunodeficiency, contributes to the prolonged survival of bacteria in the intestine.


Assuntos
Fatores Biológicos/metabolismo , Intestinos/imunologia , Infecções por Salmonella/imunologia , Salmonella enteritidis/metabolismo , Salmonella typhimurium/metabolismo , Anticorpos Antibacterianos/análise , Especificidade de Anticorpos , Fatores Biológicos/análise , Portador Sadio/imunologia , Inativadores do Complemento/análise , Inativadores do Complemento/metabolismo , Proteínas do Sistema Complemento/agonistas , Proteínas do Sistema Complemento/análise , Inibidores Enzimáticos/análise , Inibidores Enzimáticos/metabolismo , Fezes , Humanos , Imunidade Celular , Imunoglobulinas/análise , Lactoferrina/análise , Lactoferrina/antagonistas & inibidores , Muramidase/antagonistas & inibidores , Infecções por Salmonella/microbiologia , Salmonella enteritidis/imunologia , Salmonella typhimurium/imunologia
6.
Anal Quant Cytol Histol ; 20(4): 313-20, 1998 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-9739414

RESUMO

OBJECTIVE: To explore new tumor features for refined category formation that permits the tailoring of individualized treatment schemes in lung cancer. STUDY DESIGN: Survival data on patients from six independent studies on cases with surgically treated lung cancer, primary lung carcinoids or metastasizing breast carcinoma (including data on primary breast carcinoma) were analyzed by nonhierarchic multivariant discriminant analysis with respect to a set of cytometric/histometric and immunohistochemical/ligand histochemical parameters. The number of stem lines, S-phase-related tumor cell fraction and the extent of structural entropy and its current were measured. In addition, the expression of binding capacities for histo-blood group trisacharides, galectins, the alpha/beta-interferon antagonist sarcolectin, the lymphokine macrophage migration inhibitory factor and a monoclonal antibody to the Le(y) epitope was monitored for insight into aspects of immunologic and biologic behavior. RESULTS: In all studies, a correlation between tumor parameters, according to TNM stage and survival, was seen. In order to refine this category formation, at least certain selected features should provide an even more stringent association than TNM stages. Indeed, statistical correlation of the cytometric and histometric parameters as well as the expression of receptors for the two histo-blood group trisaccharides, ligands for the galectins (CL-16, CL-14) and macrophage migration inhibitory factor was stronger than that of TNM stage. A large amount of the current of structural entropy was especially highly significantly associated with poor survival. This observation could be verified in each of the different studies. CONCLUSION: The obtained data strongly support the notion that thermodynamic evaluation of tumor growth focusing on the "entropy distance" of the tumor from its environment is a promising perspective warranting extended studies. Additionally, glycohistochemical features, including binding capacities for histo-blood group trisaccharides, have the potential to aid in establishment of a biologic marker set for tumor staging.


Assuntos
Entropia , Neoplasias Pulmonares/química , Neoplasias Pulmonares/patologia , Biomarcadores Tumorais , Feminino , Histocitoquímica , Humanos , Citometria por Imagem/métodos , Ligantes , Neoplasias Pulmonares/cirurgia , Análise Multivariada , Prognóstico
7.
Biofizika ; 43(3): 447-51, 1998.
Artigo em Russo | MEDLINE | ID: mdl-9702336

RESUMO

The fluorescence with maximum at 683 nm from isolated yeast plasma membranes has been detected. The fluorescence was due to a membrane-bound compound absorbing in the visible range of the spectrum. The fluorescence excitation spectrum of this compound has a structure typical for porphyrins. At the same time, in several fluorescence properties the porphyrin localized in the plasma membrane is different from other intracellular porphyrins (protoporphyrin, coproporphyrin).


Assuntos
Candida/química , Membrana Celular/química , Porfirinas/química , Fluorescência
8.
Tumour Biol ; 19(5): 390-420, 1998.
Artigo em Inglês | MEDLINE | ID: mdl-9701730

RESUMO

The ISOBM TD-6 Workshop is the first international workshop on monoclonal antibodies against the Sialyl Lewisa (SLea) antigen. Eight research groups participated in a blind study to characterize the epitope binding, relative affinity and performance in immunoradiometric assays, of a panel of 20 monoclonal antibodies. The antibodies were tested against a diverse panel of neoglycoconjugates, purified antigens and human serum pools from gastrointestinal malignancies. Epitope specificities were determined for the majority of antibodies in the panel. Cross-reactivity with related saccharide structures was noted in several antibodies. Overall, the results of the TD-6 Workshop show further development of SLea immunoassays may yield yet more specific assays for the detection and management of gastrointestinal and other malignancies.


Assuntos
Anticorpos Monoclonais , Biomarcadores Tumorais/análise , Gangliosídeos/análise , Anticorpos Monoclonais/imunologia , Anticorpos Monoclonais/metabolismo , Especificidade de Anticorpos , Antígeno CA-19-9/imunologia , Antígeno CA-19-9/metabolismo , Sequência de Carboidratos , Epitopos/imunologia , Gangliosídeos/imunologia , Gangliosídeos/metabolismo , Neoplasias Gastrointestinais/sangue , Humanos , Ensaio Imunorradiométrico , Dados de Sequência Molecular
9.
Bioorg Khim ; 22(5): 358-65, 1996 May.
Artigo em Russo | MEDLINE | ID: mdl-8929221

RESUMO

Five IgM class monoclonal antibodies (MAb) to the SiaLea tetrasaccharide, which is known as a serologic tumor marker CA 19.9, and three MAbs (one of IgG3 and two of IgM class) to the SiaLex tetrasaccharide (differentiation antigen CD15s) were obtained against totally synthetic immunogens. The epitope specificity of the antibodies was determined using a wide range of oligosaccharides and their polyacrylamide conjugates. MAb 4E10 against SiaLea and MAb 4G5 to SiaLex were highly specific to the antigen predefined by immunization: they did not cross-react either with structurally and conformationally related oligosaccharides or with their disaccharide fragments. Two MAbs to SiaLea (D7 and E5B1) showed a weak binding to SiaLex. MAb CC1 recognized SiaLea and SiaLex almost equally, and MAb 5H9 to SiaLea cross-reacted with the non-sialylated form, the Lea trisaccharide. Two MAbs against SiaLex A3 and B11 bound to all carbohydrate structures containing the core disaccharide Gal beta 1-3(4)GlcNAc.


Assuntos
Anticorpos Monoclonais/imunologia , Gangliosídeos/imunologia , Oligossacarídeos/imunologia , Selectinas/metabolismo , Animais , Antígeno CA-19-9 , Reações Cruzadas , Gangliosídeos/metabolismo , Camundongos , Camundongos Endogâmicos BALB C , Oligossacarídeos/metabolismo , Selectinas/imunologia , Antígeno Sialil Lewis X
10.
Glycobiology ; 5(4): 385-9, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7579792

RESUMO

The monoclonal antibody LU-BCRU-G7, that was generated by in vitro immunization, shows clinical value as a prognostic marker in early stage breast carcinoma. It has now been characterized with regard to its binding epitope. Using a recently described method based on the construction of N-substituted polyacrylamide (PAA) derivatives of carbohydrates (pseudopolysaccharides), the structure of the epitope for the monoclonal antibody LU-BCRU-G7 has been determined. Competitive binding assays and inhibitory enzyme-linked immunosorbent assays (ELISAs) using these pseudopolysaccharides have shown the LU-BCRU-G7 epitope to be a disaccharide Gal beta 1-3GlcNAc (Lec; where Gal is D-galactose, Glc is D-glucose and GlcNAc is N-acetyl-D-glucosamine). Both galactose and N-acetyl glucosamine moieties are essential for binding. Substitution on C-2 or C-3 of the terminal galactose abolished binding, as did galactose-alpha terminated oligosaccharides. The galactose moiety alone, as expressed by the Gal beta-PAA conjugate, appeared to be a more important feature of the epitope than the GlcNAc-PAA conjugate, which failed to bind or inhibit the LU-BCRU-G7 antibody. In the N-acetyl glucosamine moiety, binding was decreased but not eliminated by fucose substitution, as in Lea, or change in configuration of C-4, as in Gal beta 1-3GlcNAc. Omission of the NAc group resulted in complete loss of activity. The tetrasaccharide lacto-N-tetraose, although containing the terminal Lec disaccharide, does not react with the antibody, suggesting conformational interference of the binding site.(ABSTRACT TRUNCATED AT 250 WORDS)


Assuntos
Acetilglucosamina/imunologia , Anticorpos Monoclonais/imunologia , Antígenos Glicosídicos Associados a Tumores/química , Neoplasias da Mama/imunologia , Dissacarídeos/imunologia , Galactose/imunologia , Glicoproteínas/imunologia , Especificidade de Anticorpos , Antígenos Glicosídicos Associados a Tumores/imunologia , Configuração de Carboidratos , Sequência de Carboidratos , Ensaio de Imunoadsorção Enzimática , Epitopos/química , Epitopos/imunologia , Feminino , Glicoproteínas/química , Humanos , Dados de Sequência Molecular , Estrutura Molecular , Conformação Proteica , Células Tumorais Cultivadas
11.
Bioseparation ; 5(3): 141-6, 1995 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-7655191

RESUMO

The paper deals with convenient and fast methods for purification of monoclonal antibodies (MAbs) to carbohydrate antigens Le(y) and Le(d) from the cell culture and ascite fluid by ion-exchange chromatography on S-Sepharose and salt-promoted chromatography on a "thiophilic" adsorbent. One-step procedure on S-Sepharose of MAbs to Le(y) (IgG and IgM) provides significant purification (over 90% of contaminants were removed), while a purification factor for IgM to Le(d) is much lower. Highly purified IgM to Le(d) could be obtained by a two-step purification procedure including "thiophilic-adsorption" chromatography and gel-filtration (90-98% of contaminants from the cell culture and ascite fluid were removed). The preparations of IgG and IgM retain their initial antibody activity.


Assuntos
Anticorpos Monoclonais/isolamento & purificação , Antígenos do Grupo Sanguíneo de Lewis/imunologia , Adsorção , Animais , Ascite , Cromatografia/métodos , Cromatografia em Gel/métodos , Cromatografia por Troca Iônica/métodos , Eletroforese em Gel de Poliacrilamida/métodos , Humanos , Imunoglobulina G/isolamento & purificação , Imunoglobulina M/isolamento & purificação , Antígenos do Grupo Sanguíneo de Lewis/análise , Camundongos , Camundongos Endogâmicos BALB C/imunologia , Peso Molecular , Sefarose
12.
Hybridoma ; 13(4): 295-301, 1994 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-7806250

RESUMO

Tetrasaccharide Fuc alpha 1-2Gal beta 1-4(Fuc alpha 1-3)GlcNAc is known as carbohydrate determinant of cancer- and AIDS-associated antigen Lewisy (Ley). Synthetic antigen to generate mouse monoclonal antibodies (MAbs) directed to Ley was prepared and constructed as a spacer-armed tetrasaccharide coupled with lipophilized polymer, Ley-PAA-PE, where PAA is a 30-kD polyacrylamide and PE is phosphatidylethanolamine. An efficient immune response was provided by using Ley-PAA-PE adsorbed on Salmonella minnesota. Positive hybridomas were screened by enzyme-linked immunosorbent assay (ELISA) using Ley-PAA as a coating agent. An inhibitory version of the same test system showed absolute specificity of two MAbs: only hapten Ley and Ley-PAA were strong inhibitors, in contrast to Leb, tri- and disaccharidic fragments of the mentioned tetrasaccharides, as well as their PAA-conjugates. MAbs obtained against synthetic antigen specifically stained the Ley (+) cell line A431.


Assuntos
Anticorpos Monoclonais/imunologia , Antígenos Glicosídicos Associados a Tumores/imunologia , Antígenos CD15/imunologia , Animais , Anticorpos Monoclonais/biossíntese , Especificidade de Anticorpos , Sequência de Carboidratos , Feminino , Citometria de Fluxo , Camundongos , Camundongos Endogâmicos BALB C , Dados de Sequência Molecular
13.
Artigo em Inglês | MEDLINE | ID: mdl-2900852

RESUMO

Data are presented on the detection in crude animal and human sera of Cl. perfringens phospholipase C (PLC) inhibitor. When the level of Cl. perfringens type A antitoxin is determined in the in vitro toxin neutralization test the inhibitor is found to decrease PLC activity in the test dose of experimental homologous toxin. The extent of decrease accounts for the variation of results obtained in the in vitro and in vivo toxin neutralization tests. The variation may be cancelled out by introducing a corresponding coefficient to calculate the level of alpha-antitoxin. It is suggested that the isolation and investigation of the PLC inhibitor will contribute to the development of preparations for treatment of gas gangrene due to Cl. perfringens type A.


Assuntos
Antitoxinas/análise , Toxinas Bacterianas/análise , Proteínas de Ligação ao Cálcio , Clostridium perfringens , Testes de Neutralização , Fosfolipases Tipo C/antagonistas & inibidores , Animais , Toxinas Bacterianas/imunologia , Clostridium perfringens/enzimologia , Humanos
14.
Artigo em Inglês | MEDLINE | ID: mdl-2877025

RESUMO

The paper presents the results of a study on the immunogenic properties of toxoid preparations from Cl. perfringens type A obtained using the routine method of detoxifying alpha = toxin in the culture medium (commercial preparations) and by means of detoxifying a previously purified alpha = toxin (experimental preparations). When tested in immunized guinea pigs, the immunogenicity of experimental preparations was found to be 4.5 to 6 times that of commercial preparations. In mice, there was no difference in the immunogenic properties of the two types of preparations as determined by the ED30 of the antigen and the serum levels of Cl. perfringens antitoxin. The possibility is discussed of using the guinea pig as a laboratory animal model due to its ability to reflect most clearly the differences in the immunogenicity of Cl. perfringens type A toxoid preparations.


Assuntos
Clostridium perfringens/imunologia , Imunização , Toxoides/imunologia , Animais , Antitoxinas/análise , Relação Dose-Resposta Imunológica , Cobaias , Camundongos , Testes de Neutralização
15.
Biull Eksp Biol Med ; 96(11): 82-4, 1983 Nov.
Artigo em Russo | MEDLINE | ID: mdl-6315110

RESUMO

The methods for determining the level of type A Perfringens antitoxin in human blood sera were examined and compared. The ratios for correlating the data obtained in the toxin neutralization test (NT) in vivo, in the passive hemagglutination test (PHT), and as a result of the enzyme-labeled immunosorbent assay (ELISA) with regard to the antitoxin level measured in the NT in vitro were equal to 0.88, 0.64 and 0.39, respectively. The sensitivity of the NT in vivo and in vitro was 0.25 IU/ml, that of the PHT 0.01-0.005 IU/ml, and that of the ELISA 0.01-0.02 IU/ml Perfringens antitoxin. To perform the NT, not less than 1 ml blood serum is required, while for the PHT and ELISA, 0.1-0.05 ml. Provided hyghly purified anatoxin is used for preparing the erythrocyte diagnosticum Perfringens, and polysterene plates are sensitized in performing the ELISA, all the reactions are specific. While titrating human blood sera containing type A Perfringens antitoxin, use in the PHT may be made of type A Perfringens rabbit antiserum as reference.


Assuntos
Antitoxinas/análise , Clostridium perfringens/imunologia , Toxinas Bacterianas/análise , Ensaio de Imunoadsorção Enzimática , Testes de Hemaglutinação , Humanos , Testes de Neutralização/métodos
17.
Biull Eksp Biol Med ; 92(9): 322-5, 1981 Sep.
Artigo em Russo | MEDLINE | ID: mdl-6271303

RESUMO

Immunogenic properties of Clostridium perfringens type A toxoid preparations obtained by different methods are described. As regards immunogenicity for guinea-pigs and man, toxoid obtained by the detoxification of preliminarily purified alpha-toxin (experimental toxoid) compares favourably with preparations obtained by the detoxification of alpha-toxin in a culture fluid. It was shown in experiments on guinea pigs that immunogenicity of experimental toxoid rises with the increase in the degree of purification of alpha-toxin used for detoxification. The least purified preparations turned out to be the most immunogenic for mice. In Cl. perfringens culture fluid, factor (factors) was found and separated, which reduced the immunogenicity of the respective toxoid in experiments with immunization of guinea pigs and increased it in mice. Activation of antibody-formation was disclosed to be nonspecific. The existence of this factor(s) should be taken into account in the development of vaccines and methods for evaluating their immunogenic properties.


Assuntos
Anticorpos Antibacterianos/biossíntese , Clostridium perfringens/imunologia , Gangrena Gasosa/prevenção & controle , Toxoides/imunologia , Vacinação , Animais , Cobaias , Humanos , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Endogâmicos DBA , Especificidade da Espécie
18.
Artigo em Russo | MEDLINE | ID: mdl-197752

RESUMO

Experiments were conducted on guinea pigs, rabbits and mice (mongrel and inbred); immunogenic properties of Cl. perfringens toxoids of different purity were studied. Toxin neutralization and passive hemagglutination tests were used to determine the antitoxic immunity level. It appeared that in the immunization of guinea pigs and rabbits the degree of immunogenicity of the preparations increased with the elevation of their specific activity. Under the same conditions both the mongrel and the inbred mice displayed the maximum immune response in the immunization with the least purified preparations, and the minimum after the injection of a highly purified antigen.


Assuntos
Formação de Anticorpos , Clostridium perfringens/imunologia , Toxoides/administração & dosagem , Animais , Anticorpos Antibacterianos/isolamento & purificação , Cobaias , Testes de Hemaglutinação , Imunização , Camundongos , Coelhos , Linfócitos T/imunologia
19.
Zh Mikrobiol Epidemiol Immunobiol ; (4): 110-4, 1977 Apr.
Artigo em Russo | MEDLINE | ID: mdl-868405

RESUMO

The authors present the results of comparative study of the properties of experimental perfringens toxoids obtained from purified alpha-toxoids of different degrees of purity. Experimental toxoids proved to possess a greater immunogenicity than preparations obtained by detoxication of alpha-toxin under conditions of cultural fluid, the greater--the more the purity of alpha-toxin used for procuring the experimental toxoid. C1. perfringens alpha-toxin recovered as a result of two-stage alpha-toxin purification, including its primary concentration and fractionation on DEAE-cellulose under conditions of negative alpha-toxin sorption, changed during detoxication into toxoid whose immunogenicity exceeded that of manufactured preparations 3--4 fold. The toxoid was harmless and sorbed in a dose of 100 BU on 2--3 mg of aluminium hydroxide; stability of its antigenic properties and its yield was not less than those of manufactured toxoids. Perfringens toxoid prepared from highly purified alpha-toxoid was 10 times greater by immunogenicity than the manufactured preparation, and was sorbed on 1--2 mg of aluminium hydroxide.


Assuntos
Gangrena Gasosa/prevenção & controle , Toxoides , Vacinação , Animais , Cromatografia DEAE-Celulose , Cobaias , Imunização Secundária , Coelhos , Toxoides/isolamento & purificação
20.
Biull Eksp Biol Med ; 83(2): 198-200, 1977 Feb.
Artigo em Russo | MEDLINE | ID: mdl-558013

RESUMO

Mice belonging to a number of inbred strains were immunized intradermally with Cl. oedematiens alpha-toxoid. The immunization was repeated 30 days later. On the 20th and the 30th days after the first injection and on the 10th day after the second one the antibody level against the toxoid was determined in the blood of mice by the passive hemagglutination test. The maximum response to the primary immunization was observed in the mice of the C3H strain, and the minimum one--in mice of the DBA/2 strain; the difference was more than 30-fold. The rest of the strains used in the test (A,CBA, BALB/c, AKR, CC57BR) displayed an intermediate level of the immune response. The differences reduced after the repeated immunization. The immune response to this antigen in mice is supposed to be genetically controlled.


Assuntos
Anticorpos Antibacterianos/biossíntese , Infecções por Clostridium/prevenção & controle , Toxoides/administração & dosagem , Vacinação , Animais , Infecções por Clostridium/imunologia , Camundongos , Camundongos Endogâmicos , Especificidade da Espécie
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...